Skip to main content
Scrutica

REGENERON PHARMACEUTICALS

No corporate parent is shown

0
ownership levels above this company
2
supply relationships · 1 with suppliers, 1 with customers
0
linked facilities
0
export-control designations found
0
sovereign commitments to funds investing in this company
Scrutica id
org-regeneron-pharmaceuticals
Name and corporate-form variants · 1 REGENERON PHARMACEUTICALS

Ownership chain

The main chain follows the strongest parent claim by confidence, source authority and date. Other named parents appear alongside it.

  1. REGENERON PHARMACEUTICALS

    Starting organisation.

End of the displayed chain

The displayed ownership chain ends at REGENERON PHARMACEUTICALS

Suppliers and customers

Annual dollar amounts refer to the fiscal year shown; sources include SEC filings, company disclosures and licensed supply-chain data. Figures open their source details. Disclosures more than 5 years old are marked historical. Records are grouped by counterparty, with historical records after newer or undated records within each group. A product or service, a percentage (the supplier’s share of one product line in the customer’s inputs) and a sole-source mark appear only where the record’s cited source states them for the pair; alternative suppliers may exist outside this corpus.

Upstream Suppliers · 1 record
  • Intellia Therapeutics, Inc.

    SEC segment disclosure: INTELLIA THERAPEUTICS INC → REGENERON PHARMACEUTICALS

    FY2024
Downstream Customers · 1 record

Explore full supply chain graph →

Related analysis

Source coverage

Geographic revenue, business segments and capital allocation are unavailable from the licensed financial dataset. No stock ticker or SEC filing identifier is recorded for REGENERON PHARMACEUTICALS. The public industry classification (SIC, NAICS) is also unrecorded. Sources and publication limits.